Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001382473 | SCV001581248 | pathogenic | Developmental and epileptic encephalopathy, 2; Angelman syndrome-like | 2020-05-27 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in CDKL5 are known to be pathogenic (PMID: 22872100). This nonsense change has been observed in individual(s) with CDKL5-related conditions (PMID: 26544041, 28386848). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Trp176*) in the CDKL5 gene. It is expected to result in an absent or disrupted protein product. |
Laboratorio de Genetica e Diagnostico Molecular, |
RCV002243173 | SCV002512422 | likely pathogenic | Developmental and epileptic encephalopathy, 2 | 2022-01-31 | criteria provided, single submitter | clinical testing | ACMG classification criteria: PVS1 very strong, PM2 moderate |
Centre for Population Genomics, |
RCV005053983 | SCV005687619 | pathogenic | CDKL5 disorder | 2024-12-23 | criteria provided, single submitter | curation | This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria. Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 3.0, this variant is classified as pathogenic. At least the following criteria are met: Predicted to result in loss of function, and LOF is a known mechanism of disease (PVS1). This variant has been identified as a de novo occurrence in at least 2 individuals with CDKL5 disorder, without confirmation of paternity and maternity (PM6_Strong). This variant is absent from gnomAD (PM2_Supporting). |